What The Latest TGA UDI Guidance Means For Medical Device Manufacturers
Australia’s Unique Device Identification (UDI) framework has moved from preparation to implementation. As a result, it brings new compliance responsibilities for medical device manufacturers and sponsors supplying devices in Australia.
From 1 July 2026, UDI requirements became mandatory for Class III and Class IIb medical devices, marking an important milestone in Australia’s transition to a nationally regulated UDI system. In addition, the TGA is progressively introducing the requirements for other device classes through to 2029.
Therefore, for manufacturers supplying, or planning to supply, medical devices in Australia, UDI should now be considered part of the broader regulatory compliance framework rather than simply a labelling exercise.
What is changing?
Specifically, Australia’s UDI system is intended to provide consistent identification of medical devices throughout their lifecycle. Moreover, it aims to improve device traceability, particularly during post-market activities such as safety investigations and recalls.
In particular, devices within scope must meet applicable requirements relating to UDI identifiers, labelling and packaging, and the submission of device information to the Australian Unique Device Identification Database (AusUDID).
Importantly, UDI requirements apply in addition to existing regulatory obligations for medical devices supplied in Australia. Likewise, they sit alongside labelling and ARTG duties rather than replacing them.
The AusUDID is now an important part of compliance
Furthermore, the Australian Unique Device Identification Database (AusUDID) is the central database supporting Australia’s UDI system. It stores UDI records for medical devices supplied in Australia. Therefore, manufacturers and sponsors need to consider the consistency and accuracy of information across device labels, packaging, regulatory documentation and UDI records.
Consequently, this means manufacturers should consider consistency across:
- Device labels and packaging
- UDI records
- ARTG information
- Instructions for Use
- Patient Information Leaflets, where applicable
- Manufacturer product information
- Regulatory and technical documentation
Above all, it’s important to note that UDI data should be treated as regulated product information requiring ongoing governance, rather than simply as a one-time database submission.
Understanding UDI identifiers
Next, manufacturers and sponsors should work together to ensure device data submitted to the AusUDID is complete, accurate and consistent with the device being supplied. For example, the TGA provides an Australian UDI Data Dictionary describing the information fields, permitted values and other metadata used within the AusUDID.
Similarly, this becomes particularly important where manufacturers maintain large device portfolios, multiple packaging levels, numerous models or variants, or devices supplied by more than one Australian sponsor.
What manufacturers should do now
Determine whether UDI requirements apply to each device
First, review the classification and device type and determine the applicable implementation timeframe, rather than assuming that the same requirements apply across an entire portfolio. In addition, the TGA provides specific guidance to help manufacturers and sponsors determine which devices are within scope.
Confirm your compliance date
Second, Australia is introducing mandatory UDI requirements progressively according to device classification. Therefore, manufacturers should identify the applicable compliance date for every affected product family and incorporate these dates into their regulatory planning.
Confirm your UDI strategy
Then, determine the appropriate identifiers for your devices and confirm that the UDI and UDI carrier meet applicable Australian requirements. Besides that, manufacturers supplying products internationally should also assess how their existing global UDI processes interact with Australian requirements.
Review labels and packaging
After that, assess whether UDI information is correctly applied at the required packaging levels and determine whether any specific requirements apply to the device.
Prepare and validate AusUDID data
Meanwhile, identify the required data elements and compare them with existing product master data, regulatory documentation and ARTG information.
Check consistency across regulatory documentation
In other words, UDI information should align with relevant labels, Instructions for Use, product descriptions, regulatory information and other controlled documentation.
Establish change-control processes
Additionally, manufacturers should understand which product changes may require changes to UDI information or the allocation of a new UDI-DI. Accordingly, UDI considerations should therefore be incorporated into existing quality and regulatory change-control processes.
Define responsibilities between manufacturer and Australian sponsor
Finally, where the manufacturer is located outside Australia, responsibilities for generating, providing, submitting, maintaining and updating UDI information should be clearly established between the manufacturer and sponsor.
For example, for detailed implementation guidance, manufacturers and sponsors should refer directly to the TGA’s guidance below.
UDI should be integrated into the quality system
Overall, one of the most important practical considerations is that UDI compliance should not operate as a standalone regulatory project. Instead, UDI can affect:
- Labelling controls
- Product master data
- Regulatory records
- Change control
- Post-market surveillance
- Recalls and other market actions
- Communication between manufacturers and Australian sponsors
Hence, manufacturers should therefore consider incorporating UDI responsibilities into their Quality Management System and regulatory lifecycle processes, including procedures for reviewing and maintaining AusUDID information after initial submission.
What happens if a manufacturer cannot comply?
However, where an affected device cannot meet applicable UDI requirements by its compliance date, a sponsor may need to consider the TGA’s Consent to Supply pathway for UDI-related non-compliance. Still, consent is assessed by the TGA and should not be treated as a substitute for establishing an appropriate UDI compliance strategy.
In that case, manufacturers identifying potential compliance gaps should assess them early and determine whether corrective action can be completed before affected devices are supplied.
Preparing for the next phase
In summary, the introduction of Australia’s UDI framework represents more than the addition of another identifier to medical device packaging. Rather, it creates a structured connection between the physical device, its regulatory information and its presence on the Australian market.
Meanwhile, for manufacturers, particularly those supplying devices internationally, the opportunity is to integrate Australian UDI requirements into existing global identification and regulatory processes while identifying Australian-specific requirements early.
In conclusion, a structured UDI readiness assessment can help identify gaps across device identifiers, labels, packaging, product data, ARTG information, AusUDID records and internal quality-system processes before they become compliance issues.
How RQSolutions can help
In addition, RQSolutions supports medical device manufacturers and sponsors in understanding and implementing Australian regulatory requirements. Specifically, we can assist with:
- Assessing UDI applicability and compliance timeframes
- Reviewing device and packaging information
- Evaluating AusUDID data readiness
- Identifying gaps between existing documentation and Australian requirements
- Reviewing manufacturer and sponsor responsibilities
- Integrating UDI requirements into broader Australian market-access and regulatory strategie
Further information
Finally, for the latest regulatory information, visit the TGA Unique Device Identification (UDI) Hub.
This article provides general regulatory information and is not intended to constitute legal or regulatory advice. Regulatory requirements should be assessed in relation to the particular device and circumstances.